FRI0143 Type I Interferon Plays A Key Role in Immunogenicity and Lupus-Like Autoimmunity in Patients...
FRI0143 Type I Interferon Plays A Key Role in Immunogenicity and Lupus-Like Autoimmunity in Patients with Rheumatoid Arthritis Treated by Infliximab
About this item
Full title
Author / Creator
Ishikawa, Y. , Fujii, T. , Kondo-Ishikawa, S. , Hashimoto, M. , Furu, M. , Ito, H. , Imura, Y. , Yukawa, N. , Yoshifuji, H. , Ohmura, K. and Mimori, T.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
More information
Scope and Contents
Contents
BackgroundImmunogenicity, a formation of anti-drug antibodies (ADA) against a biologic agent, has had an impact in patients with rheumatoid arthritis (RA) receiving anti-TNF antibody (Ab) treatment because it is strongly linked to sub-therapeutic serum drug levels and a lack of clinical response [1]. We previously reported the association between i...
Alternative Titles
Full title
FRI0143 Type I Interferon Plays A Key Role in Immunogenicity and Lupus-Like Autoimmunity in Patients with Rheumatoid Arthritis Treated by Infliximab
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1901773093
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1901773093
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2015-eular.1567
